The Efficacy and Safety of P2Y(12) Inhibitors After a Short Course of Three Months or Less of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention and Drug-Eluting Stent Placement: A Meta-Analysis
Meeting Abstract (Web of Science)